A U.S. Food and Drug Administration advisory panel is slated to vote Thursday on whether to recommend the approval of the Moderna coronavirus vaccine for emergency use.

If approved, it would be the second available in the U.S. behind Pfizer's vaccine, which was granted emergency authorization last week.

The two vaccines are largely similar:

Data shows both are between 94 to 95% effective.
Both require two doses.
Neither is a live virus vaccine.
Neither impacts your body's DNA.
Reported side effects for both are nearly identical: mild fever, headache, fatigue, pain at the injection site.
Both use new vaccine technology called mRNA.

свернуть